Effects of PUVA and mechlorethamine treatment of psoriatic patients on epidermal Langerhans´ cells
DOI:
https://doi.org/10.2340/0001555567532535Abstract
Using OKT6 monoclonal antibody, we investigated the number of epidermal Langerhans´ cells (LCs) in involved skin from patients with psoriasis, before and after mechlorethamine (HN2) or PUVA treatment. The number of LCs remained at about pretreatment number during three weeks of HN2 treatment alone, though they were reduced after 10 systemic PUVA treatments. Therefore, in contrast to PUVA which influences LCs, HN2 seems to have little effect on LCs. LCs in psoriatic plaques were, in number, 3-4 times less numerous than those in uninvolved, nontreated epidermis.Downloads
Download data is not yet available.
Downloads
Published
1987-11-01
How to Cite
Torinuki, W., Mauduit G, Haftek, M., & Thivolet J. (1987). Effects of PUVA and mechlorethamine treatment of psoriatic patients on epidermal Langerhans´ cells. Acta Dermato-Venereologica, 67(6), 532–535. https://doi.org/10.2340/0001555567532535
Issue
Section
Articles
License
LicenseAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
